Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet (London, England)（2023）
摘要
National Institute of Health Research.
更多查看译文
关键词
tubal ectopic pregnancy,gefitinib,methotrexate,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要